Keren Haruvi Snir

A value creator in the biopharmaceutical space, Keren brings more than 20 years of experience in the pharmaceutical industry marked by success leading major M&A deals, enterprise innovations, and complex market strategies for large-scale, sustainable growth. In her current role as President of Sandoz North America, she leads Sandoz’s largest commercial and country organization – the United States – which is responsible for approximately a quarter of the global revenue for Sandoz Inc. She also oversees Sandoz commercial operations in Canada and is a member of the Global Sandoz Leadership Team and Executive Committee. Keren is also Chair of the Association for Accessible Medicines (AAM) for 2024. AAM works to ensure more generic and biosimilar medicines are accessible to more people who need them. Prior to joining Sandoz, Keren served as Global Head of M&A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management.